Recent News

• 03.10.2025 - Leerink's Global Healthcare Conference 2025
• 03.10.2025 - KalVista Pharmaceuticals to Host Investor Webcast Highlighting Commercialization Strategy, Plans and Progress for Sebetralstat in Hereditary Angioedema
• 03.10.2025 - KalVista Pharmaceuticals to Host Investor Webcast Highlighting Commercialization Strategy, Plans and Progress for Sebetralstat in Hereditary Angioedema
• 03.04.2025 - TD Cowen 45th Annual Health Care Conference
• 03.04.2025 - KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 03.04.2025 - KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 03.03.2025 - KalVista Pharmaceuticals Shares Latest Sebetralstat Findings at the American Academy of Allergy, Asthma & Immunology 2025 Annual Meeting
• 03.03.2025 - KalVista Pharmaceuticals Shares Latest Sebetralstat Findings at the American Academy of Allergy, Asthma & Immunology 2025 Annual Meeting
• 02.24.2025 - KalVista Pharmaceuticals to Present at Upcoming Investor Conferences
• 02.24.2025 - KalVista Pharmaceuticals to Present at Upcoming Investor Conferences

Recent Filings

• 03.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.25.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.25.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.25.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.25.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities